Literature DB >> 10465511

Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding.

J E Morley1, M M Alshaher, S A Farr, J F Flood, V B Kumar.   

Abstract

Recent studies have suggested a role for nitric oxide in the regulation of food intake. Neuropeptide Y (NPY) is one of the most potent orexigenic agents. Chronic administration of leptin decreases food intake. This study examined the effects of NPY and leptin on nitric oxide synthase (NOS) in the hypothalamus. Previously it has been demonstrated that obese (ob/ob) mice have elevated NOS levels in the hypothalamus. In this study we demonstrated that the administration of leptin (6 microg/day) subcutaneously (SC) for 3 days decreased body weight (P < 0.001) and food intake P < 0.001) in obese (ob/ob) mice as expected. In addition, leptin decreased NOS in the hypothalamus nu 37% (P < 0.01) and in brown adipose tissue by 69% (P < 0.01) but not in white adipose tissue. NPY was administered intracerebroventricularly to CD-1 mice at doses of 0.25 and 0.50 microg. Mice were sacrificed 15 min after injection and NOS was measured in their hypothalami. NPY at the lower dose increased NOS in the hypothalamus by 147%. These results, taken together, with previously published studies support the concept that nitric oxide may play a role as a mediator of the effects of NPY and leptin on food intake. The alterations of NOS in brown adipose tissue following leptin administration could result in changes in blood flow or metabolism in the brown fat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465511     DOI: 10.1016/s0196-9781(99)00012-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

Review 1.  Frailty and hormones.

Authors:  John E Morley; Moon Jong Kim; Matthew T Haren
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation.

Authors:  Jussara M do Carmo; Mirian Bassi; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

4.  cGMP modulates responses to queen mandibular pheromone in worker honey bees.

Authors:  Brendon L Fussnecker; Alexander M McKenzie; Christina M Grozinger
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2011-05-31       Impact factor: 1.836

5.  Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus.

Authors:  Guillaume Osterstock; Pauline Escobar; Violeta Mitutsova; Laurie-Anne Gouty-Colomer; Pierre Fontanaud; François Molino; Jean-Alain Fehrentz; Danielle Carmignac; Jean Martinez; Nathalie C Guerineau; Iain C A F Robinson; Patrice Mollard; Pierre-François Méry
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

6.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus.

Authors:  Shenglong Zou; Rishi K Somvanshi; Seungil Paik; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

7.  Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.

Authors:  Xiang Yi; Dongfen Yuan; Susan A Farr; William A Banks; Chi-Duen Poon; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-02       Impact factor: 9.776

8.  Intracellular nitric oxide mediates neuroproliferative effect of neuropeptide y on postnatal hippocampal precursor cells.

Authors:  Angela Cheung; Philip L Newland; Malik Zaben; George S Attard; William P Gray
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

9.  iNOS promotes hypothalamic insulin resistance associated with deregulation of energy balance and obesity in rodents.

Authors:  Carlos Kiyoshi Katashima; Vagner Ramon Rodrigues Silva; Luciene Lenhare; Rodrigo Miguel Marin; José Barreto Campello Carvalheira
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

Review 10.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.